Today's noteworthy downgrades include: 3D Systems (DDD) downgraded to Hold from Buy at Canaccord... Akorn (AKRX) downgraded to Neutral from Overweight at Piper Jaffray... Allegiant Travel (ALGT) downgraded to Fair Value from Buy at CRT Capital... Altera (ALTR) downgraded to Neutral from Outperform at Baird... Amazon.com (AMZN) downgraded on valuation at Argus... American Science & Engineering (ASEI) downgraded to Sell from Fair Value at CRT Capital... Basic Energy (BAS) downgraded to Underperform from Neutral at Macquarie... C.H. Robinson (CHRW) downgraded to Sell from Neutral at UBS... Celladon (CLDN) downgraded to Neutral from Buy at Roth Capital... DST Systems (DST) downgraded to Neutral from Outperform at Credit Suisse... DeVry (DV) downgraded on weaker than expected outlook at Stifel... Eaton Vance (EV) downgraded to Sell from Neutral at Citigroup... Emerge Energy (EMES) downgraded to Hold from Buy at Wunderlich... FMC Technologies (FTI) downgraded to Accumulate from Speculative Buy at Global Hunter... Fibria Celulose (FBR) downgraded to Underweight from Equal Weight at Morgan Stanley... Forum Energy (FET) downgraded to Neutral at Baird... Gulf Island Fabrication (GIFI) downgraded to Hold from Accumulate at Johnson Rice... Hancock Holding (HBHC) downgraded to Hold from Buy at Drexel Hamilton... Hi-Crush Partners (HCLP) downgraded to Hold from Buy at Wunderlich... Houghton Mifflin (HMHC) downgraded to Neutral from Buy at Citigroup (Friday)... Infosys (INFY) downgraded to Hold from Buy at Deutsche Bank... Marvell (MRVL) downgraded to Hold from Buy at Craig-Hallum... Merge Healthcare (MRGE) downgraded to Hold from Buy at Topeka... Oceaneering (OII) downgraded to Neutral from Buy at Goldman... Omega Healthcare (OHI) downgraded at BofA/Merrill... Perrigo (PRGO) downgraded to Neutral from Buy at UBS... Petrobras (PBR) downgraded to Underweight from Equal Weight at Morgan Stanley... Procter & Gamble (PG) downgraded on lack of upside at CLSA... ResMed (RMD) downgraded to Neutral from Buy at Goldman... Seadrill (SDRL) downgraded to Sell from Neutral at Citigroup... Six Flags (SIX) downgraded to Neutral from Buy at Goldman... Stratasys (SSYS) downgraded to Hold at Canaccord... Telecom Italia (TI) downgraded to Neutral from Buy at BofA/Merrill... Twitter (TWTR) downgraded to Neutral from Buy at SunTrust... United Continental (UAL) downgraded to Fair Value from Buy at CRT Capital... Virgin America (VA) downgraded to Sell from Buy at CRT Capital.

Shares of sleep apnea device makers ResMed (RMD) and Inspire Medical (INSP) are moving in opposite directions after Eli Lilly (LLY) announced topline results of the SURMOUNT-OSA Phase 3 clinical trials, showing tirzepatide injection significantly reduced the apnea-hypopnea index, or AHI, compared to placebo, achieving the primary endpoints of the studies. After initially moving... To see the rest of the story go to thefly.com. See Story Here

Says without approximately $200M impact Boeing (BA) 737 MAX 9 from grounding, United (UAL) would have reported a quarterly profit.

Seaport Research raised the firm's price target on United Airlines to $66 from $60 and keeps a Buy rating on the shares. The company reported Q1 results that "handily bettered consensus," the analyst tells investors. The firm notes no change has been made to its thesis made in January, but notes consensus for the year has to move higher.

Check out this morning's top movers from around Wall Street, compiled by The Fly.  HIGHER - Alcoa (AA)... To see the rest of the story go to thefly.com. See Story Here

Shares of sleep apnea device makers ResMed (RMD) and Inspire Medical (INSP) are slipping in early trading after Eli Lilly (LLY) announced topline results of the SURMOUNT-OSA phase 3 clinical trials that showed tirzepatide injection significantly reduced the apnea-hypopnea index, or AHI, compared to placebo, achieving the primary endpoints of the studies. SURMOUNT-OSA Study 1 evaluated tirzepatide, which Lilly identifies as "the only approved GIP and GLP-1 treatment for chronic weight management, commercialized as Zepbound in the U.S. and Mounjaro in some global markets outside the U.S.," in adults with moderate-to-severe obstructive sleep apnea, or OSA, and obesity who were not on positive airway pressure, or PAP, therapy for 52 weeks. In Wednesday pre-market trading, ResMed shares are down about 3% to $180, while Inspire shares have slipped about 1% to $220.

As previously reported, Maxim analyst Tom Forte initiated coverage of Amazon.com with a Buy rating and $218 price target. The firm believes the company will be able to exploit consumer internet trends that include advertising, artificial intelligence, cloud computing, healthcare, logistics, and over-the-top, or OTT, video. The firm projects a compound annual sales growth rate of 6.5% from 2023-2026, which it notes compares to 14.2% in the prior three-year period.

Maxim initiated coverage of Amazon.com with a Buy rating and $218 price target.

Enthusiast Gaming Holdings (EGLXF) announced that in partnership with Amazon (AMZN), its esports team, Luminosity will be hosting a Rocket League invitational event featuring North America's top-ranked teams and players to promote Amazon Prime. The two-day invitational event will be hosted by Sean 'Spaceman' Rogers and Jack 'Corelli' Collier and feature eight of the top professional North American Rocket League teams, including Luminosity's very own, as they compete to earn a $15,000 prize pool on April 30th and May 1st. Throughout the tournament, players will be able to use unlimited boost as part of the 'Prime Boost Advantage' while Luminosity will run dynamic overlays that encourage fans to boost their shopping and streaming experience with Amazon. To promote the event, participants will be actively posting on their personal social media accounts and streaming their perspective of the event. In addition, the Company is pleased to announce that its previously announced sale of select non-core and non-profitable casual gaming assets has closed. Among the assets included as part of the divestment were Shockwave, LittleBigSnake, MathGames.com, and TypeRacer.com. Further details on the transaction can be found in the Company's press release dated April 1, 2024.

Amazon's HQ2 in Arlington, Virginia lost 200 jobs in 2023, missing the company's goal of adding 2,500 jobs, The Washington Post's Teo Armus reports. Amazon's HQ2 has roughly 8,000 employees and plans to reach about 25,000 by the end of the decade, according to its agreement with Virginia, Armus writes. Reference Link